Ghasemi Shima, Torab Zeinab, Shirmohammadi Adileh, Babaloo Amirreza, Johari Reza, Farhadi Farrokh, Mobasseri Majid, Mohammadi Hamidreza
Department of Prosthodontics, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Pediatric Dentistry, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
J Adv Periodontol Implant Dent. 2022 Mar 13;14(1):32-37. doi: 10.34172/japid.2022.003. eCollection 2022.
This clinical trial evaluated the effect of coenzyme Q10 supplementation along with scaling and root planing (SRP) on periodontal and gingival indices in controlled diabetic patients.
Forty-two diabetic patients (controlled type), referred to the Department of Periodontics with chronic periodontitis and eligible for the study, were included in the study. Patients suffering from chronic periodontitis with a probing pocket depth of ≥5 mm in different quadrants of the oral cavity with radiographic evidence of bone loss were included in the present randomized, double-masked, placebo-controlled clinical trial. The subjects were instructed to take one capsule of coenzyme Q10 or a placebo every day for 30 days following SRP. Clinical parameters, i.e., plaque index (PI), gingival index (GI), bleeding on probing (BOP), clinical attachment level (CAL), and probing pocket depth (PPD), were recorded at baseline and four weeks after treatment by two masked and calibrated examiners. The study results were reported as (mean ± standard deviations) and frequencies (percentages).
One month after the intervention, PPD, CAL, BOP, and PI indices in the intervention group were significantly lower than those in the control group. One month after the intervention, the GI was similar in both groups. A significant decrease was observed in the GI in both groups after the intervention.
The results of the present study showed that Q10 orally with scaling and root planing in patients with controlled diabetes with chronic periodontitis might accelerate the treatment process and significantly reduce the pocket depth.
本临床试验评估了补充辅酶Q10联合龈下刮治和根面平整术(SRP)对糖尿病控制良好患者牙周和牙龈指标的影响。
42例患有慢性牙周炎且符合研究条件的糖尿病控制良好患者被纳入本研究,这些患者被转诊至牙周病科。患有慢性牙周炎且口腔不同象限探诊袋深度≥5 mm并有骨质流失影像学证据的患者被纳入本随机、双盲、安慰剂对照临床试验。受试者在接受SRP治疗后,被要求连续30天每天服用一粒辅酶Q10胶囊或一粒安慰剂。由两名经过校准的盲法检查者在基线和治疗后四周记录临床参数,即菌斑指数(PI)、牙龈指数(GI)、探诊出血(BOP)、临床附着水平(CAL)和探诊袋深度(PPD)。研究结果以(平均值±标准差)和频率(百分比)报告。
干预后一个月,干预组的PPD、CAL、BOP和PI指数显著低于对照组。干预后一个月,两组的GI相似。干预后两组的GI均显著下降。
本研究结果表明,在患有慢性牙周炎的糖尿病控制良好患者中,口服辅酶Q10联合龈下刮治和根面平整术可能会加速治疗进程并显著减少袋深度。